🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "targeted action to address cost of living challenges" in the forthcoming financial statement.

Speaking to media outlets, she stated that reducing inflation is a collective duty of both the government and the central bank.

The UK's price growth is projected to be the most elevated among the G7 advanced economies this year and next.

Potential Utility Cost Interventions

Reports indicate the administration could intervene to lower utility costs, for instance by cutting the present 5% rate of VAT charged on energy supplies.

Another possibility is to lower some of the regulatory levies presently included in bills.

Fiscal Constraints and Expert Predictions

The government will obtain the latest assessment from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for such measures.

The view from most analysts is that Reeves will have to declare tax increases or spending cuts in order to fulfill her declared debt limits.

Earlier on the same day, analysis showed there was a £22 billion gap for the chancellor to address, which is at the lower end of expectations.

"There's a collective task between the central bank and the administration to continue tackling some of the causes of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Pledges and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent information from the fiscal watchdog had not changed her commitment to election pledges not to raise rates on income tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with rising international and commercial issues for the Budget tax moves, probably to be focused on those "wealthiest."

International Trade Tensions

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "Our security interests always come first."

Recent declaration by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are essential for high-technology manufacturing led American leader Donald Trump to suggest an additional 100% import tax on goods from China, increasing the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "economic coercion" and "a global supply chain control attempt."

Questioned on considering the American proposal to join its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the global economy and generates further obstacles."

"In my view there are sectors where we must confront Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was cooperating with international partners "on our own critical minerals strategy, so that we are less reliant."

NHS Medicine Costs and Investment

The Chancellor also acknowledged that the price the National Health Service spends on drugs could increase as a result of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

A number of the biggest global drug companies have said in recent statements that they are either pausing or canceling operations in the United Kingdom, with some attributing the low prices they are getting.

Recently, the Science Minister said the cost the NHS spends on medicines would have to increase to prevent companies and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed the BBC: "It has been observed as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to ensure that people getting care from the National Health Service are can obtain the top critical medicines in the world. And so we are looking at this situation, and... aiming to secure additional funding into Britain."